0

Tissue Microarray Analysis of Hormonal Signaling Pathways in Uterine Carcinosarcoma

Gloria S Huang, Rebecca C Arend, Maomi Li, Marc J Gunter, Lydia G Chiu, Susan Band Horwitz, Gary L Goldberg

Am J Obstet Gynecol. 2009 Apr;200(4):457.e1-5.

PMID: 19200930

Abstract:

Objectives:
To evaluate the relationship of hormone (estrogen receptor alpha, estrogen receptor beta, progesterone receptor) and growth factor receptor (insulin-like growth factor receptor, human epidermal growth factor receptor 2) expression with disease progression in uterine carcinosarcoma.
Study design:
Immunohistochemistry was performed on tissue arrays using standard methodology. Differences between groups were evaluated by the Wilcoxon rank-sum test. Interactions between tumor stage and receptor expression were determined by linear trend analysis.
Results:
Compared with normal endometrium, carcinosarcomas exhibited low estrogen receptor alpha and progesterone receptor expression (all P < .01), but overexpressed estrogen receptor beta (P = .02). Estrogen receptor beta expression increased in advanced stage disease (P = .02). Insulin-like growth factor receptor expression was lower in carcinosarcoma compared with normal endometrium (P = .01). Human epidermal growth factor receptor 2 expression was elevated and increased with disease progression (P < .01).
Conclusion:
In uterine carcinosarcoma, estrogen receptor beta expression is elevated and increases with disease progression, whereas estrogen receptor alpha and progesterone receptor are suppressed. Human epidermal growth factor receptor 2 expression is increased, whereas insulin-like growth factor receptor is lower than in normal endometrium. These data support a potential role for estrogen receptor beta in disease progression via crosstalk with human epidermal growth factor receptor 2.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
IAR4248881 sRank Receptor human sRank Receptor human Price
qrcode